BioCatalyst

OCUL — OCULAR THERAPEUTIX, INC catalysts

1 verified catalyst event(s) for OCULAR THERAPEUTIX, INC (ticker OCUL). Each is linked to its official source. Verified as of 2026-09-22.

Next verified catalyst

2027-01-08 — Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Su · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-08
in 4mo
ESTIMATED
 READOUT
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Impl
Phase 3 · Neovascular Age-related Macular Degeneration
 OCUL OCULAR THERAPEUTIX, INC OTX-TKI, Aflibercept, Aflibercept ClinicalTrials.gov ↗
✓ Source-checked 2026-09-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.